BCS: Implications on Guidelines and Policies for Drug Products Approval Worldwide (including ICH and Regional)

Iain McGilverary of McGilveray Pharmacon discusses implications of the Biopharmaceutical Classification System for drug policies, regulations, and approval processes at the Controlled Release Society symposium sponsored by Capsugel.

Download White Paper